Drugs cost too much. There is a better way to fund medical innovation

Drugs Medicine 2018 United Nations

UNICEF/Olivier Asselin In Côte d’Ivoire, a counsellor from UNICEF partner NGO Femme Active, instructs an adolescent boy, diagnosed with HIV in 2012, on how to take his antiretroviral (ARV) medication correctly.

This article is brought to you based on the strategic cooperation of The European Sting with the World Economic Forum.

Author: Rufus Pollock, Lead, iMed Project, and Founder and President of Open Knowledge

Drugs are expensive. Very expensive, and becoming ever more so, it seems. Prices for new medicines have been steadily rising for the past few decades. It costs a great deal to bring new drugs to market, the explanation goes, and without high prices, the pipeline of new medicines will run dry.

This argument is unsustainable, especially when even the world’s most developed economies and healthcare systems are struggling to afford vital medicines. To keep paying more for drugs simply cannot be the answer. Bad health affects everyone. We should be urgently seeking new mechanisms of funding medical innovation that do not compromise on access.

There is a strong moral and social obligation for exploring alternatives. Millions of people globally do not have access to the medicines they need to survive. In the US, millions of adults skip prescribed medications due to the high cost. The same is true in Canada, where the public healthcare system does not usually extend to cover prescription medicines, and in Europe, especially in poorer members of the EU.

The situation is worse in less developed countries. Many pay out of pocket for drugs, and the hefty price tags can run many times the annual average income. Two widely used drugs for treating hepatitis C cost the equivalent of one or more years’ average earnings in 12 out of 30 countries, revealed a recent study by the World Health Organization. Millions are dying because they cannot afford the medicine they need to stay alive.

When some members of society lack medicine, there are consequences beyond the individual directly affected. The increased morbidity caused by a lack of access to medication places an extraordinary strain on healthcare systems, exacerbating the drain on their resources from ever more expensive drugs. In addition, unhealthy populations are far less economically productive than healthy ones. Beyond social justice, there are clear economic reasons to find new models of funding medical innovation that do not restrict access to medicine.

The current state of affairs is making the world a more dangerous place. Healthcare systems that are strained by increased morbidity, and by a critical lack of money and medicine, are less likely to be able to contain outbreaks when they occur. Poor global health increases global instability. Failing to ensure everyone has access to necessary medication can have profound knock-on consequences and worsen existing crises.

Moreover, the high sale price of drugs skews incentives for innovation towards wealthy consumers. This means that vital medicines for certain ailments are not accessible when needed on a global scale. For instance, the Ebola virus had been known about for decades before the recent outbreak, and yet virtually no treatments were available. The whole world is unprepared and at risk.

The explanation that pharmaceutical companies offer for high drug prices is compelling. It costs a great deal of money to bring a drug to market, they argue. This is why so many reluctantly accept the current state of affairs, in which innovation justifies restricted access. Though it is true that drugs do cost a lot to bring to market, there is a remarkable lack of consensus on exactly how much.

This is compounded by a systemic lack of transparency. It is often not known how much is spent on what, and how reliant private-sector developments are on publicly funded research. Often, medicines that are developed with significant help from public funds do not reflect that support in prices, and there is no guarantee under the monopoly rights patent system that they should.

Moreover, a great deal of money that could be earmarked for research is spent on marketing instead. Indeed, in some large drug companies, expenditure on marketing outweighs that on research.

This model is unsustainable. So long as we continue to reward innovation through a single channel – buying the drug – access to new medicines will be limited. Ultimately, the problem is about how we pay for medicine. Today, we only pay by purchasing the end product. This means that the costs of manufacture (which is cheap) and innovation (which is expensive) are rolled into one. This puts access and innovation in conflict.

If we were to change how we fund medicines, there could be no conflict. Incentives for innovation and access to affordable drugs could co-exist. We can fund research and production separately. There is no excuse for not exploring the wide systemic changes needed to make that happen.

Today’s model is unsustainable, unhealthy and utterly unnecessary. We can have new medicines and wide access to them. We should be working towards this as a matter of urgency.

And we have ideas. For example, at the iMed Project we’ve been developing innovative two-part payment models for funding medicines that would maintain incentives for innovators while making treatment at cost of manufacture.”

the sting Milestone

Featured Stings

Can we feed everyone without unleashing disaster? Read on

These campaigners want to give a quarter of the UK back to nature

How to build a more resilient and inclusive global system

Stopping antimicrobial resistance would cost just USD 2 per person a year

Three tips for breaking through bias and seeing evidence more clearly

Indonesia has a plan to deal with its plastic waste problem

Mental health during COVID-19 outbreak: who takes care of health professionals?

JADE visits Lithuanian Junior Initiatives

Mobile technology saving lives: Changing healthcare systems with simple technology solutions

‘Historic’ new Syria talks should focus on relief for war-weary civilians, says UN negotiator

Brexit: new European Parliament reaffirms wholehearted support for EU position

Scientists can lead the fight against fake news

The refugee crisis seen through the eyes of a young doctor from Turkey

New research reveals the true extent of corruption in fisheries

New tech infrastructure will help economies recover after COVID-19

Pride in health care during Pride Month: Are we ready for a dignified health care for LGBTQI+ patients?

Survivors of ISIL terror in Iraq want justice, not revenge, says head of UN investigation team

Assassinations in Ethiopia amidst regional ‘coup’ attempt, condemned by UN chief

MEPs propose more transparent legislative drafting and use of allowances

How fintech is setting Southeast Asia’s SMEs free

Europe and UN form bulwark against ‘might makes right’ worldview, EU foreign affairs chief tells Security Council

Sustainable Development Summit: ‘We must step up our efforts – now’, Guterres declares

Dangers of poor quality health care revealed ‘in all countries’: WHO report

Independent UN rights expert calls for compassion, not sanctions on Venezuela

Why press freedom should be at the top of everyone’s agenda

Draghi indirectly accuses Germany of using double standards in financial issues

Why the UN is investigating poverty in the United Kingdom

Access to health in the developped and developing world

State aid: Commission approves Luxembourg guarantee measure to further support economy in coronavirus outbreak

Breaking news on European Youth Employment: European Youth Forum Guide tackles poor quality internships!

How three US cities are using data to end homelessness

Rule of Law: European Commission refers Poland to the Court of Justice to protect judges from political control

Mobile technology facilitating social distance in the middle of a pandemic

Sydney is choking on record levels of smog – and the bushfire season is just getting started

Smokers who quit one month before surgery reap benefits: UN health agency

European Youth Forum @ European Business Summit 2015: Why interns should matter to business

The first new university in the UK for 40 years is taking a very different approach to education

Societies must unite against ‘global crisis of antisemitic hatred’, Guterres urges

Four lessons from Africa on building effective business ecosystems

Scientists have created the world’s ‘first psychopath AI’

EU growth in 2015 to be again sluggish; Can the Juncker Commission fight this out?

Education should be like everything else. An on-demand service

Friday’s Daily Brief: human rights in Sudan, sombre anniversaries for Rwanda and Nigeria, and fears of ‘chaos’ in Libya

World Health Organization calls crisis meeting over deadly Ebola outbreak in DR Congo

So, what is your favourite Sustainable Development Goal?

An alternative to the future of antimicrobial therapy

Is Haiti better prepared for disasters, nine years on from the 2010 earthquake?

Syria: ‘Deplorable’ violence in Idlib against civilians, humanitarian workers must ‘stop immediately’: UN Coordinator

Bundestag kick starts the next episode of the Greek tragedy

Over $39 million earmarked by UN-backed fund to combat effects of climate change in Nepal

Digitalization is changing banking – These 3 trends will help shape its future

Europe is ready to engage, von der Leyen tells annual EU Ambassadors’ Conference

Coronavirus: EU Civil Protection Mechanism activated for the repatriation of EU citizens

A new generation of women leaders is making waves in the Arab world

Teenagers’ career expectations narrowing to limited range of jobs, OECD PISA report finds

State aid: Commission approves €30 million Estonian measure to support Nordica in the context of the coronavirus outbreak

UN spotlights digitization of audiovisual archives to preserve human history on World Day

The European Parliament fails to really restrict the rating agencies

Islamophobia is driving more US Muslims to become politically engaged, suggests report

AIDEX 2015: Humanitarian Hero Award Winner Announced

New UN-supported farming app is cream of crop in tackling Sahel pest

State of the Energy Union: Progress made on the clean energy transition and a basis for green recovery

We have solutions to crime. We just need to scale them

More Stings?

Advertising

Speak your Mind Here

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s